Replies to post #32064 on Biotech Values

[DewDiligence]

Welcome to the board. I haven’t followed those two companies, so I will defer to those who have. Regards, Dew

[poorgradstudent]

ovarex

http://www.jco.org/cgi/reprint/21/13/2460

The above is a trial using 3 or 12 cycles of paclitaxel as consolidation therapy after a confirmed complete response. Three cycles of paclitaxel is considered the control arm, and showed a PFS of 21 months. It's not the same as watchful waiting, so I guess it is up to you to decide how much of an advantage 3 cycles of paclitaxel provides versus no treatment.